Merete Rønn Lasnier ~ Preventive health strategist’s Post

View profile for Merete Rønn Lasnier ~ Preventive health strategist

Helping businesses & governments invest in health before illness – cutting costs & boosting longevity | Founder at Your Longevity | HealthTech innovator | Scaling health solutions

How much is a vision worth to you? Let's disrupt startup valuations for real impact. Thomas Visti's post on valuation sparked something in me. It got even deeper after my chat with Kim Østergaard today. It made me think deeply about how we value our startup. Inspired by them, I'm being transparent about how I value Your Longevity. Your Longevity is seeking 100,000 EUR for a 15% share, valuing us at 670K EUR (5 million DKK).💵 This valuation reflects our clear growth plans, strong KPIs, and a unique market position in personalized health, especially with the growing demand for longevity among people 40+. 4 WHYs for Your Longevity's Valuation 1️⃣ Why 3x ROI by 2028? We expect 3x return by 2028 thanks to our scalable SaaS model, growing health tech market, and a projected €1 million revenue by 2027. The health tech market in Europe is also expected to grow 8% per year, reaching €75 billion by 2030. 2️⃣ Why invest in health tech? To control health: invest in preventive measures, 8% market growth! Preventive health is crucial, especially for people 40+. In Europe, 35-50% of this age group suffers from lifestyle diseases. We aim to help people take control of their health in a market growing 8% annually, currently valued at €75 billion. 3️⃣ Why our customer acquisition strategy works Our CAC starts at €500 due to launch costs but will lower by 20-30% by year two. With a target market of 10 million people in Europe, we believe in strong growth potential and scalability. 4️⃣ Why the market is ready 1 in 3 people worldwide suffer from lifestyle diseases, and in Europe 35-50%. Our population is aging but also becoming more ill. Statistics show that people in their 40s and 50s are becoming sicker, often stuck in pain and illness compared to previous generations. In many ways, our healthcare system keeps us alive, but falls short in terms of prevention. Growth milestones ↳100 clients by Q1 2025, growing to 500 clients by end of 2026. ↳Scalable onboarding using tech and automation to grow without big costs. Investment Breakdown ↳ 30% product development: AI, new features, real-time updates. ↳25% marketing & sales: Get customers, build partnerships, boost brand. ↳Remaining funds: Infrastructure, operations, salary, and growth in Europe. I'm sharing this plan to show our investment logic, tied to clear KPIs and milestones. I'd love to hear your thoughts on our valuation, vision, or growth plan. Let's create a healthier future together! ✌️ Join our journey. What are your thoughts on our valuation strategy? Let's learn from each other 👇 Share your insights in the comments! #Investment #Startups #Valuation #YourLongevity #KPI #InvestorCall

Kim Østergaard

Investor & Founder at OneProgram, HjemIgen, Mindturn, TaskPlatform, ServiceStyring, Avecdo, MyPressWire, AskHome, Gandium, MarketingPlatform (sold) and other companies. 3x Gazelle winner.

4mo

It’s always a question about the founder / founding team. Preseed is difficult to value. So far an idea is just an idea. From an investor point of view it’s a question of the team can 10x your investment. With a minimum of risk.

To view or add a comment, sign in

Explore topics